0001631569-23-000006.txt : 20230104 0001631569-23-000006.hdr.sgml : 20230104 20230104163652 ACCESSION NUMBER: 0001631569-23-000006 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20230104 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230104 DATE AS OF CHANGE: 20230104 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Community Healthcare Trust Inc CENTRAL INDEX KEY: 0001631569 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] IRS NUMBER: 465212033 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37401 FILM NUMBER: 23507116 BUSINESS ADDRESS: STREET 1: 3326 ASPEN GROVE DRIVE STREET 2: SUITE 150 CITY: FRANKLIN STATE: TN ZIP: 37067 BUSINESS PHONE: 615-771-3052 MAIL ADDRESS: STREET 1: 3326 ASPEN GROVE DRIVE STREET 2: SUITE 150 CITY: FRANKLIN STATE: TN ZIP: 37067 8-K 1 chct-20230104.htm 8-K chct-20230104
false0001631569Maryland00016315692023-01-042023-01-04


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

FORM 8-K

CURRENT REPORT
Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): January 4, 2023

COMMUNITY HEALTHCARE TRUST INCORPORATED
(Exact Name of Registrant as Specified in Charter)
MARYLAND 001-37401 46-5212033
(State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer
Identification No.)

3326 Aspen Grove Drive, Suite 150, Franklin, Tennessee 37067
(Address of principal executive offices) (Zip Code)

(615) 771-3052
(Registrant's telephone number, including area code)

Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each ClassTrading SymbolName of each exchange on which registered
Common stock, $0.01 par value per shareCHCTNew York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



Item 5.02    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(e) On October 27, 2022, the Board of Directors (the “Board”) of Community Healthcare Trust Incorporated (the “Company”), at the recommendation of the compensation committee of the Board (the “Committee”), authorized and approved the Seventh Amendment (the “Wallace Sixth Amendment”) to the Employment Agreement by and between the Company and Timothy G. Wallace (the “Wallace Employment Agreement”), the Fourth Amendment (the “Dupuy Third Amendment”) to the Employment Agreement by and between the Company and David H. Dupuy (the “Dupuy Employment Agreement”), the Fourth Amendment (the “Stach Third Amendment”) to the Amended and Restated Employment Agreement by and between the Company and Leigh Ann Stach (the “Stach Employment Agreement”), and the Second Amendment (the “Meyer First Amendment”) to the Employment Agreement by and between the Company and Timothy L. Meyer (the “Meyer Employment Agreement”). These amendments to each respective employment agreements were executed on January 3, 2023 and were effective as of January 1, 2023.
Wallace Employment Agreement
The principal change in the Wallace Employment Agreement resulting from the Wallace Seventh Amendment is to increase the base salary paid by the Company to Timothy G. Wallace for his employment as President and Chief Executive Officer (“Wallace Base Salary”). In 2022, the Wallace Base Salary was $794,200.00. The Wallace Seventh Amendment increases the Wallace Base Salary to $863,295.00 for 2023, which is a $69,095.00 increase from 2022.
The foregoing descriptions of the Wallace Seventh Amendment to the Wallace Employment Agreement are qualified in their entirety by reference to the original Wallace Employment Agreement, which is included as Exhibit 10.6 to the Registration Statement on Form S-11 of the Company filed with the Securities and Exchange Commission (the "SEC") on April 2, 2015, the first amendment to the Wallace Employment Agreement, which is included as Exhibit 10.1 to the Current Report on Form 8-K filed with the SEC on January 18, 2017, the second amendment to the Wallace Employment Agreement, which is included as Exhibit 10.1 to the Current Report on Form 8-K filed with the SEC on January 2, 2018, the third amendment to the Wallace Employment Agreement, which is included as Exhibit 10.1 to the Current Report on Form 8-K filed with the SEC on January 3, 2019, the fourth amendment to the Wallace Employment Agreement, which is included as Exhibit 10.1 to the Current Report on Form 8-K filed with the SEC on January 3, 2020, the fifth amendment to the Wallace Employment Agreement, which is included as Exhibit 10.1 to the Current Report on Form 8-K filed with the SEC on January 4, 2021, the sixth amendment to the Wallace Employment Agreement, which is included as Exhibit 10.1 to the Current Report on Form 8-K filed with the SEC on January 4, 2022, and the Wallace Seventh Amendment, which is included as Exhibit 10.1 to this Current Report on Form 8-K, and are incorporated by reference into this Item. The foregoing description of the Wallace Seventh Amendment does not purport to be complete and is qualified in its entirety by reference to such exhibits.
Dupuy Employment Agreement
The principal change in the Dupuy Employment Agreement resulting from the Dupuy Fourth Amendment is to increase the base salary paid by the Company to David H. Dupuy for his employment as Executive Vice President and Chief Financial Officer (“Dupuy Base Salary”). In 2022, the Dupuy Base Salary was $487,200.00. The Dupuy Fourth Amendment increases the Dupuy Base Salary to $529,586.00 for 2023, which is a $42,386.00 increase from 2022.
The foregoing descriptions of the Dupuy Third Amendment to the Dupuy Employment Agreement are qualified in their entirety by reference to the Dupuy Employment Agreement, which is included as Exhibit 10.1 to the Current Report on Form 8-K filed with the SEC on March 11, 2019, the first amendment to the Dupuy Employment Agreement, which is included as Exhibit 10.2 to the Current Report on Form 8-K filed with the SEC on January 3, 2020, the second amendment to the Dupuy Employment Agreement, which is included as Exhibit 10.2 to the Current Report on Form 8-K filed with the SEC on January 4, 2021, the third amendment to the Dupuy Employment Agreement, which is included as Exhibit 10.2 to the Current Report on Form 8-K filed with the SEC on January 4, 2022, and the Dupuy Fourth Amendment, which is included as Exhibit 10.2 to this Current Report on Form 8-K, and are incorporated by reference into this Item. The foregoing description of the Dupuy Fourth Amendment does not purport to be complete and is qualified in its entirety by reference to such exhibits.
Stach Employment Agreement
The principal change in the Stach Employment Agreement resulting from the Stach Fourth Amendment is to increase the base salary paid by the Company to Leigh Ann Stach for her employment as Executive Vice President and Chief Accounting Officer (“Stach Base Salary”). In 2022, the Stach Base Salary was $410,500.00. The Stach Fourth Amendment increases the Stach Base Salary to $446,214.00 for 2023, which is a $35,714.00 increase from 2022.
2


The foregoing descriptions of the Stach Fourth Amendment to the Stach Employment Agreement are qualified in their entirety by reference to the amended and restated Stach Employment Agreement, which is included as Exhibit 10.1 to the Current Report on Form 8-K filed with the SEC on May 3, 2019, the first amendment to the Stach Employment Agreement, which is included as Exhibit 10.4 to the Current Report on Form 8-K filed with the SEC on January 3, 2020, the second amendment to the Stach Employment Agreement, which is included as Exhibit 10.3 to the Current Report on Form 8-K filed with the SEC on January 4, 2021, the third amendment to the Stach Employment Agreement, which is included as Exhibit 10.3 to the Current Report on Form 8-K filed with the SEC on January 4, 2022, and the Stach Fourth Amendment, which is included as Exhibit 10.3 to this Current Report on Form 8-K, and are incorporated by reference into this Item. The foregoing description of the Stach Fourth Amendment does not purport to be complete and is qualified in its entirety by reference to such exhibits.
Meyer Employment Agreement
The principal change in the Meyer Employment Agreement resulting from the Meyer Second Amendment is to increase the base salary paid by the Company to Timothy L. Meyer for his employment as Executive Vice President - Asset Management (“Meyer Base Salary”). In 2022, the Meyer Base Salary was $312,400.00. The Meyer Second Amendment increases the Meyer Base Salary to $339,579.00 for 2023, which is a $27,179.00 increase from 2022.
The foregoing descriptions of the Meyer Second Amendment to the Meyer Employment Agreement are qualified in their entirety by reference to the Meyer Employment Agreement, which is included as Exhibit 10.1 to the Form 10-Q for the Quarter Ended September 30, 2021 filed with the SEC on November 2, 2021, the Meyer first amendment to the Meyer Employment Agreement, which is included as Exhibit 10.4 to the Current Report on Form 8-K filed with the SEC on January 4, 2022, and the Meyer Second Amendment, which is included as Exhibit 10.4 to this Current Report on Form 8-K, and are incorporated by reference into this Item. The foregoing description of the Meyer Second Amendment does not purport to be complete and is qualified in its entirety by reference to such exhibits.

    
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits
Exhibit NumberDescription of Exhibits
10.1
10.2
10.3
10.4
104Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document)

3



SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 COMMUNITY HEALTHCARE TRUST INCORPORATED
 By:
/s/ David H. Dupuy
Executive Vice President and
Chief Financial Officer
Date: January 4, 2023  

4

 EX-10.1 2 exh101_wallaceamendx2023.htm EX-10.1 Document

Exhibit 10.1


COMMUNITY HEALTHCARE TRUST
INCORPORATED

SEVENTH AMENDMENT TO EMPLOYMENT AGREEMENT
    THIS SEVENTH AMENDMENT TO THE EMPLOYMENT AGREEMENT (the “Seventh Amendment”) by and between Community Healthcare Trust Incorporated, a Maryland corporation (the “Corporation”), and TIMOTHY G. WALLACE (“Officer”) is made and entered into as of January 3, 2023 and effective as of January 1, 2023 (the “Effective Date”).
RECITALS
    WHEREAS, the Corporation and Officer have entered into that certain Employment Agreement dated April 1, 2014 (the “Employment Agreement”), as amended by the First Amendment to the Employment Agreement (the "First Amendment") dated January 12, 2017, by the Second Amendment to the Employment Agreement (the "Second Amendment") dated January 2, 2018, by the Third Amendment to the Employment Agreement (the "Third Amendment") dated January 3, 2019, by the Fourth Amendment to the Employment Agreement (the "Fourth Amendment") dated January 3, 2020, by the Fifth Amendment to the Employment Agreement (the "Fifth Amendment") dated January 4, 2021, and by the Sixth Amendment to the Employment Agreement (the "Fifth Amendment") dated January 4, 2022;
    WHEREAS, in a meeting on October 27, 2022, the Board of Directors of the Corporation, at the recommendation of the Compensation Committee of the Corporation, approved a salary adjustment for the Officer through an amendment to the Employment Agreement; and
    WHEREAS, pursuant to Section 8.3 of the Employment Agreement, any modification to the Employment Agreement must be in writing and signed by the party against whom enforcement of such modification is sought.
    NOW, THEREFORE, in consideration of the foregoing premises, and other good and valuable consideration, the receipt and sufficiency of which are hereby affirmed, the parties hereto agree to the following:
    1.    Amendment. The first sentence of Section 3.1 of the Employment Agreement, as amended by the First Amendment, Second Amendment, Third Amendment, Fourth Amendment, Fifth Amendment, and Sixth Amendment, is hereby deleted and replaced in its entirety by the following:
As payment for the services to be rendered by Officer as provided in Section 1 and subject to the terms and conditions of Section 2, Corporation agrees to pay to Officer a “Base Salary” of $863,295.00 per annum effective as of the Effective Date, payable in 24 equal semi-monthly installments, or in such other periodic installments as mutually agreed to by the Corporation and Officer.
    2.    No Further Amendment; Controlling Instrument. Except as provided herein, the Employment Agreement shall remain in full force and effect and without other changes. In the event of a conflict between the terms of this Seventh Amendment, the Employment Agreement, the First Amendment, the Second Amendment, the Third Amendment, the Fourth Amendment, the Fifth Amendment, or the Sixth Amendment, this Seventh Amendment shall control.
    3.    Employment Agreement. From and after the date of this Seventh Amendment, any and all terms referring to the Employment Agreement, as used in all of the documents evidencing the employment of the Officer, shall mean the Employment Agreement as amended by this Seventh Amendment.
1

    4.    Binding Effect. This Seventh Amendment shall be binding upon the parties, their respective successors, and assigns.
    5.    Counterparts. This Seventh Amendment may be executed in any number of counterparts, each of which will be deemed to be an original. Any or all counterpart originals may be executed by facsimile signature, each such signature to be deemed an original signature.
    IN WITNESS WHEREOF, the parties hereto have executed and delivered this Seventh Amendment as of January 3, 2023, to be effective as of the Effective Date.
COMPANY:
COMMUNITY HEALTHCARE TRUST INCORPORATED
By:/s/ David H. Dupuy
Name:David H. Dupuy
Title:Executive Vice President & Chief Financial Officer
OFFICER:
/s/ Timothy G. Wallace
Timothy G. Wallace
President and Chief Executive Officer


2
 EX-10.2 3 exh102_dupuyamendx2023.htm EX-10.2 Document

Exhibit 10.2


COMMUNITY HEALTHCARE TRUST
INCORPORATED

FOURTH AMENDMENT TO EMPLOYMENT AGREEMENT
    THIS FOURTH AMENDMENT TO THE EMPLOYMENT AGREEMENT (the “Fourth Amendment”) by and between Community Healthcare Trust Incorporated, a Maryland corporation (the “Corporation”), and DAVID H. DUPUY (“Officer”) is made and entered into as of January 3, 2023 and effective as of January 1, 2023 (the “Effective Date”).
RECITALS
    WHEREAS, the Corporation and Officer have entered into that certain Employment Agreement dated March 11, 2019 (the “Employment Agreement”), by the First Amendment to the Employment Agreement (the "First Amendment") dated January 3, 2020, by the Second Amendment to the Employment Agreement (the "Second Amendment") dated January 4, 2021, and by the Third Amendment to the Employment Agreement (the "Third Amendment") dated January 4, 2022;
    WHEREAS, in a meeting on October 27, 2022, the Board of Directors of the Corporation, at the recommendation of the Compensation Committee of the Corporation, approved a salary adjustment for the Officer through an amendment to the Employment Agreement; and
    WHEREAS, pursuant to Section 8.3 of the Employment Agreement, any modification to the Employment Agreement must be in writing and signed by the party against whom enforcement of such modification is sought.
    NOW, THEREFORE, in consideration of the foregoing premises, and other good and valuable consideration, the receipt and sufficiency of which are hereby affirmed, the parties hereto agree to the following:
    1.    Amendment. The first sentence of Section 3.1 of the Employment Agreement, as amended by the First Amendment, the Second Amendment and the Third Amendment, is hereby deleted and replaced in its entirety by the following:
As payment for the services to be rendered by Officer as provided in Section 1 and subject to the terms and conditions of Section 2, Corporation agrees to pay to Officer a “Base Salary” of $529,586.00 per annum effective as of the Effective Date, payable in 24 equal semi-monthly installments, or in such other periodic installments as mutually agreed to by the Corporation and Officer.
    2.    No Further Amendment; Controlling Instrument. Except as provided herein, the Employment Agreement shall remain in full force and effect and without other changes. In the event of a conflict between the terms of this Fourth Amendment, the Employment Agreement, the First Amendment, the Second Amendment, or the Third Amendment, this Fourth Amendment shall control.
    3.    Employment Agreement. From and after the date of this Fourth Amendment, any and all terms referring to the Employment Agreement, as used in all of the documents evidencing the employment of the Officer, shall mean the Employment Agreement as amended by this Fourth Amendment.
    4.    Binding Effect. This Fourth Amendment shall be binding upon the parties, their respective successors, and assigns.
    5.    Counterparts. This Fourth Amendment may be executed in any number of counterparts, each of
1

which will be deemed to be an original. Any or all counterpart originals may be executed by facsimile signature, each such signature to be deemed an original signature.


IN WITNESS WHEREOF, the parties hereto have executed and delivered this Fourth Amendment as of January 3, 2023, to be effective as of the Effective Date.
COMPANY:
COMMUNITY HEALTHCARE TRUST INCORPORATED
By:/s/ Timothy G. Wallace
Name:Timothy G. Wallace
Title:President & Chief Executive Officer
OFFICER:
/s/ David H. Dupuy
David H. Dupuy
Executive Vice President and Chief Financial Officer


2
 EX-10.3 4 exh103_stachamendx2023.htm EX-10.3 Document

Exhibit 10.3



COMMUNITY HEALTHCARE TRUST
INCORPORATED

FOURTH AMENDMENT TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT
    THIS FOURTH AMENDMENT TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Fourth Amendment”) by and between Community Healthcare Trust Incorporated, a Maryland corporation (the “Corporation”), and LEIGH ANN STACH (“Officer”) is made and entered into as of January 3, 2023 and effective as of January 1, 2023 (the “Effective Date”).
RECITALS
    WHEREAS, the Corporation and Officer have entered into that certain Amended and Restated Employment Agreement dated May 1, 2019 (the “Employment Agreement”), by the First Amendment to the Employment Agreement (the "First Amendment") dated January 3, 2020, by the Second Amendment to the Employment Agreement (the "Second Amendment") dated January 4, 2021, and by the Third Amendment to the Employment Agreement (the "Third Amendment") dated January 4, 2022;
    WHEREAS, in a meeting on October 27, 2022, the Board of Directors of the Corporation, at the recommendation of the Compensation Committee of the Corporation, approved a salary adjustment for the Officer through an amendment to the Employment Agreement; and
    WHEREAS, pursuant to Section 8.3 of the Employment Agreement, any modification to the Employment Agreement must be in writing and signed by the party against whom enforcement of such modification is sought.
    NOW, THEREFORE, in consideration of the foregoing premises, and other good and valuable consideration, the receipt and sufficiency of which are hereby affirmed, the parties hereto agree to the following:
    1.    Amendment. The first sentence of Section 3.1 of the Employment Agreement, as amended by the First Amendment, the Second Amendment, and the Third Amendment, is hereby deleted and replaced in its entirety by the following:
As payment for the services to be rendered by Officer as provided in Section 1 and subject to the terms and conditions of Section 2, Corporation agrees to pay to Officer a “Base Salary” of $446,214.00 per annum effective as of the Effective Date, payable in 24 equal semi-monthly installments, or in such other periodic installments as mutually agreed to by the Corporation and Officer.
    2.    No Further Amendment; Controlling Instrument. Except as provided herein, the Employment Agreement shall remain in full force and effect and without other changes. In the event of a conflict between the terms of this Fourth Amendment, the Employment Agreement, the First Amendment, the Second Amendment, or the Third Amendment, this Fourth Amendment shall control.
    3.    Employment Agreement. From and after the date of this Fourth Amendment, any and all terms referring to the Employment Agreement, as used in all of the documents evidencing the employment of the Officer, shall mean the Employment Agreement as amended by this Fourth Amendment.
    4.    Binding Effect. This Fourth Amendment shall be binding upon the parties, their respective successors, and assigns.
1


    5.    Counterparts. This Fourth Amendment may be executed in any number of counterparts, each of which will be deemed to be an original. Any or all counterpart originals may be executed by facsimile signature, each such signature to be deemed an original signature.
    
    
    IN WITNESS WHEREOF, the parties hereto have executed and delivered this Fourth Amendment as of January 3, 2023, to be effective as of the Effective Date.
COMPANY:
COMMUNITY HEALTHCARE TRUST INCORPORATED
By:/s/ Timothy G. Wallace
Name:Timothy G. Wallace
Title:President and Chief Executive Officer
OFFICER:
/s/ Leigh Ann Stach
Leigh Ann Stach, Executive Vice President and Chief Accounting Officer



2

 EX-10.4 5 exh104_meyeramendx2023.htm EX-10.4 Document

Exhibit 10.4


COMMUNITY HEALTHCARE TRUST
INCORPORATED

SECOND AMENDMENT TO EMPLOYMENT AGREEMENT
    THIS SECOND AMENDMENT TO THE EMPLOYMENT AGREEMENT (the “Second Amendment”) by and between Community Healthcare Trust Incorporated, a Maryland corporation (the “Corporation”), and TIMOTHY L. MEYER (“Officer”) is made and entered into as of January 3, 2023 and effective as of January 1, 2023 (the “Effective Date”).
RECITALS
    WHEREAS, the Corporation and Officer have entered into that certain Employment Agreement dated October 1, 2021 (the “Employment Agreement”), and by the First Amendment to the Employment Agreement (the "First Amendment") dated January 4, 2022;
    WHEREAS, in a meeting on October 27, 2022, the Board of Directors of the Corporation, at the recommendation of the Compensation Committee of the Corporation, approved a salary adjustment for the Officer through an amendment to the Employment Agreement; and
    WHEREAS, pursuant to Section 8.3 of the Employment Agreement, any modification to the Employment Agreement must be in writing and signed by the party against whom enforcement of such modification is sought.
    NOW, THEREFORE, in consideration of the foregoing premises, and other good and valuable consideration, the receipt and sufficiency of which are hereby affirmed, the parties hereto agree to the following:
    1.    Amendment. The first sentence of Section 3.1 of the Employment Agreement, as amended by the First Amendment, is hereby deleted and replaced in its entirety by the following:
As payment for the services to be rendered by Officer as provided in Section 1 and subject to the terms and conditions of Section 2, Corporation agrees to pay to Officer a “Base Salary” of $339,579.00 per annum effective as of the Effective Date, payable in 24 equal semi-monthly installments, or in such other periodic installments as mutually agreed to by the Corporation and Officer.
    2.    No Further Amendment; Controlling Instrument. Except as provided herein, the Employment Agreement shall remain in full force and effect and without other changes. In the event of a conflict between the terms of this Second Amendment, the Employment Agreement, or the First Amendment, this Second Amendment shall control.
    3.    Employment Agreement. From and after the date of this Second Amendment, any and all terms referring to the Employment Agreement, as used in all of the documents evidencing the employment of the Officer, shall mean the Employment Agreement as amended by this Second Amendment.
    4.    Binding Effect. This Second Amendment shall be binding upon the parties, their respective successors, and assigns.
    5.    Counterparts. This Second Amendment may be executed in any number of counterparts, each of which will be deemed to be an original. Any or all counterpart originals may be executed by facsimile signature, each such signature to be deemed an original signature.
1


    IN WITNESS WHEREOF, the parties hereto have executed and delivered this Second Amendment as of January 3, 2022, to be effective as of the Effective Date.
COMPANY:
COMMUNITY HEALTHCARE TRUST INCORPORATED
By:/s/ Timothy G. Wallace
Name:Timothy G. Wallace
Title:President & Chief Executive Officer
OFFICER:
/s/ Timothy L. Meyer
Timothy L. Meyer
Executive Vice President - Asset Management


2
 EX-101.SCH 6 chct-20230104.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 7 chct-20230104_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Entity Central Index Key Entity Central Index Key Entity Address, Address Line Two Entity Address, Address Line Two Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Trading Symbol Trading Symbol Entity File Number Entity File Number Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Soliciting Material Soliciting Material Entity Address, City or Town Entity Address, City or Town Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Local Phone Number Local Phone Number Entity Address, Postal Zip Code Entity Address, Postal Zip Code Written Communications Written Communications City Area Code City Area Code Cover [Abstract] Cover [Abstract] Title of 12(b) Security Title of 12(b) Security Document Type Document Type Amendment Flag Amendment Flag Security Exchange Name Security Exchange Name Entity Registrant Name Entity Registrant Name Entity Emerging Growth Company Entity Emerging Growth Company Entity Address, State or Province Entity Address, State or Province Document Period End Date Document Period End Date Pre-commencement Tender Offer Pre-commencement Tender Offer EX-101.PRE 8 chct-20230104_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 9 R1.htm IDEA: XBRL DOCUMENT v3.22.4
Cover Page
Jan. 04, 2023
Cover [Abstract]  
Document Type 8-K
Document Period End Date Jan. 04, 2023
Entity Registrant Name COMMUNITY HEALTHCARE TRUST INC
Entity Incorporation, State or Country Code MD
Entity File Number 001-37401
Entity Tax Identification Number 46-5212033
Entity Address, Address Line One 3326 Aspen Grove Drive
Entity Address, Address Line Two Suite 150
Entity Address, City or Town Franklin
Entity Address, State or Province TN
Entity Address, Postal Zip Code 37067
City Area Code 615
Local Phone Number 771-3052
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common stock, $0.01 par value per share
Trading Symbol CHCT
Security Exchange Name NYSE
Entity Emerging Growth Company false
Amendment Flag false
Entity Central Index Key 0001631569
XML 10 chct-20230104_htm.xml IDEA: XBRL DOCUMENT 0001631569 2023-01-04 2023-01-04 false 0001631569 MD 8-K 2023-01-04 COMMUNITY HEALTHCARE TRUST INC 001-37401 46-5212033 3326 Aspen Grove Drive Suite 150 Franklin TN 37067 615 771-3052 false false false false Common stock, $0.01 par value per share CHCT NYSE false EXCEL 11 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 12 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.4 html 1 23 1 false 0 0 false 0 false false R1.htm 0000001 - Document - Cover Page Sheet http://chct.reit/role/CoverPage Cover Page Cover 1 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityIncorporationStateCountryCode - chct-20230104.htm 4 chct-20230104.htm chct-20230104.xsd chct-20230104_lab.xml chct-20230104_pre.xml exh101_wallaceamendx2023.htm exh102_dupuyamendx2023.htm exh103_stachamendx2023.htm exh104_meyeramendx2023.htm http://xbrl.sec.gov/dei/2022 true false JSON 17 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "chct-20230104.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 23 }, "contextCount": 1, "dts": { "inline": { "local": [ "chct-20230104.htm" ] }, "labelLink": { "local": [ "chct-20230104_lab.xml" ] }, "presentationLink": { "local": [ "chct-20230104_pre.xml" ] }, "schema": { "local": [ "chct-20230104.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 3, "total": 3 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 0, "memberStandard": 0, "nsprefix": "chct", "nsuri": "http://chct.reit/20230104", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "chct-20230104.htm", "contextRef": "iaddc7819ff204570898a3cdad23d3346_D20230104-20230104", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0000001 - Document - Cover Page", "menuCat": "Cover", "order": "1", "role": "http://chct.reit/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "chct-20230104.htm", "contextRef": "iaddc7819ff204570898a3cdad23d3346_D20230104-20230104", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://chct.reit/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://chct.reit/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://chct.reit/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://chct.reit/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://chct.reit/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://chct.reit/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://chct.reit/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://chct.reit/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://chct.reit/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://chct.reit/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://chct.reit/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://chct.reit/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://chct.reit/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://chct.reit/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://chct.reit/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://chct.reit/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://chct.reit/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://chct.reit/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://chct.reit/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://chct.reit/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://chct.reit/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://chct.reit/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://chct.reit/role/CoverPage" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 18 0001631569-23-000006-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001631569-23-000006-xbrl.zip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end